Oncolytics Biotech Inc.

NASDAQ: ONCY · Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM

Oncolytics Biotech Income Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 403K 392K 452.06K
Gross Profit
n/a -403K -392K -452.06K
Operating Income
-34.98M -33.79M -28.57M -26.23M
Interest Income
n/a 1.33M 528K 98.61K
Pretax Income
-31.58M -27.66M -24.75M -26.25M
Net Income
-31.71M -27.75M -24.84M -26.3M
Selling & General & Admin
13.34M 16.08M 11.49M 12.86M
Research & Development
21.65M 17.71M 15.43M 12.92M
Other Expenses
n/a n/a n/a 13.31M
Operating Expenses
34.98M 33.79M 26.92M 26.23M
Interest Expense
n/a n/a 528K n/a
Selling & Marketing Expenses
n/a n/a n/a -452.49K
Cost & Expenses
34.98M 33.79M 26.92M 26.23M
Income Tax Expense
130K 97K 84K 49.43K
Shares Outstanding (Basic)
76.48M 67.62M 58.03M 53.51M
Shares Outstanding (Diluted)
76.48M 67.62M 58.03M 53.51M
EPS (Basic)
-0.41 -0.41 -0.43 -0.49
EPS (Diluted)
-0.41 -0.41 -0.43 -0.49
EBITDA
-34.88M -33.71M -26.83M -25.66M
EBIT
-34.98M -33.79M -26.92M -26.23M
Depreciation & Amortization
102K 81K 392K 452.06K